ArticlePloS one2024

Evaluation of hematological changes and immune response biomarkers as a prognostic factor in critical patients with COVID-19.

Liliane Rosa Alves Manaças et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.